340B Remains In the Spotlight, With New Legislation, Court Battles, and the Pending Rebate Model Launch

Thanks to everyone who voted in Friday’s poll. Interestingly, those of you who left comments suggested that there wouldn’t be a lot of forces acting to push Kennedy out. And

Near-Term Programming Note: Cost Curve is off tomorrow, back Friday for AbbVie earnings and whatever other fun befalls us in the next 48 hours. Long-Term Programming Note: I plan to

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.